57041-95-9

Basic information

• Product Name: 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI)
• Synonyms: 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI);6-aMinopyridazin-3-ol;6-Aminopyridazin-3(2H)-one;6-Aminopyridazin-3-ol, 3-Amino-1,6-dihydro-6-oxopyridazine;3-Amino-6-hydroxypyridazine
• CAS NO: 57041-95-9
• Molecular Formula: C₄H₅N₃O
• Molecular Weight: 111.104
• Product Categories: VARIOUSAMINE
• Mol File: 57041-95-9.mol
• Article Data: 1

Chemical Properties

• Melting Point: 245-246 °C (decomp)
• Appearance: /
• Density: 1.55±0.1 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 10.87±0.40(Predicted)
• CAS DataBase Reference: 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI)(57041-95-9)
• EPA Substance Registry System: 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI)(57041-95-9)

Safety Data

• Hazardous Substances Data: 57041-95-9(Hazardous Substances Data)

Usage

General Description

3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI) is a chemical compound with the molecular formula C4H4N4O. It is a pyridazine derivative, which means it contains a six-membered ring with two nitrogen atoms at the 1 and 2 positions and two double bonds. The compound is classified as an amino pyridazine, as it contains an amino group (-NH2) attached to the sixth position of the pyridazinone ring. 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI) has potential applications in pharmaceuticals, agrochemicals, and other industrial uses due to its unique chemical and biological properties. It is important for researchers to study and understand the properties and potential uses of 3(2H)-Pyridazinone,6-amino-(6CI,7CI,9CI) to fully exploit its potential in various fields.

Upstream product

• 80-32-0 sulfachloropyridazine 

Relevant articles and documents

Photocatalytic degradation kinetics and mechanism of environmental pharmaceuticals in aqueous suspension of TiO2: A case of sulfa drugs

The photocatalytic degradation kinetics of three sulfa pharmaceuticals has been investigated in TiO2 aqueous suspension. The disappearance of these three compounds follows a pseudo-first-order kinetics according to the Langmuir-Hinshelwood (L-H) model. The effects of catalyst amount, initial pH value, and initial concentration of each substrate on the photocatalytic degradation rates were measured in detail. It was observed that the surface reaction on TiO2 played an important role in the degradation of sulfa pharmaceuticals, and the further study of reactive oxygen species (ROSs) indicated that both photohole (h+) and especial hydroxyl radical (OH), were responsible for the major degradation of sulfa pharmaceuticals. The fates of the sulfur and nitrogen elements in various sulfa pharmaceuticals as well as total organic carbon (TOC) were examined following their photocatalytic transformation. The data showed that all three pharmaceuticals could be completely mineralized into CO2, H2O and inorganic ions within 240 min. These results indicated that many intermediates were produced during the photocatalytic transformation of sulfa pharmaceuticals process. Based on the identified intermediates, two tentative degradation pathways for the photocatalytic degradation of sulfa pharmaceuticals were proposed, for example hydroxylation addition to parent pharmaceuticals and the cleavage of S-N bond from the sulfaniline attacked by photohole.